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Introduction {#sec001}
============

Amoebiasis, a disease caused by the protozoan parasite *Entamoeba histolytica*, is the second cause of death due to intestinal parasitic infections \[[@pone.0156018.ref001], [@pone.0156018.ref002]\]. The Global Burden of Diseases, Injuries, and Risk Factors Study estimated in 55,500 the number of deaths due to amoebiasis worldwide in 2010 \[[@pone.0156018.ref003]\]. Amoebiasis is acquired by ingesting water or food contaminated with *E*. *histolytica* cysts. This latent stage, whose chitin wall allows for its survival outside the host, is responsible for disseminating the parasite from one host to another, spreading the disease. Excystation occurs once the cyst reaches the small intestine, particularly the ileum, releasing trophozoites, the parasite stage that proliferates in the human large intestine and is responsible for the symptoms of amoebiasis \[[@pone.0156018.ref001], [@pone.0156018.ref004]\]. Most studies on *E*. *histolytica* infection have focused on the trophozoite stage, which is relatively easy to grow in axenic culture media. Unfortunately, information on the cyst stage is very scarce due to its inability to replicate and the lack of reproducible methods for promoting trophozoite encystment and cyst excystation *in vitro*.

Recently, omics technologies have provided large amounts of information on genome expression. While over 15 transcriptome studies have been performed on *E*. *histolytica* trophozoites under different conditions, to our knowledge only one study has been done on the cyst stage \[[@pone.0156018.ref005]--[@pone.0156018.ref008]\]. The same goes for proteomic studies on amoebiasis. Most works have focused on analyzing the expression profiles of trophozoites in different cell organelles under various conditions. By two-dimensional electrophoresis followed by MS, it has been analyzed whole extracts, and both soluble and insoluble proteins (400--1500 spots) \[[@pone.0156018.ref009], [@pone.0156018.ref010]\], several membrane, cytoskeletal, and signaling-associated proteins as well as metabolic and ribosomal proteins attached to the Gal/GalNac lectin \[[@pone.0156018.ref011]\]. Other studies have included phagosome composition and proteins associated to the phagocytosis process \[[@pone.0156018.ref012]--[@pone.0156018.ref016]\], the cell surface proteome that identified 12 protein families \[[@pone.0156018.ref017]\], the pre-mRNA splicing complexes that identified 36 proteins as involved, and other 50 proteins as possibly involved in co-transcriptional processes \[[@pone.0156018.ref018]\], 33 proteins modulated in cells overexpressing the EhPC4 transcription factor \[[@pone.0156018.ref019]\] and a pull-down assay that identified two endoribonucleases interacting with the EhCAF1 deadenylase \[[@pone.0156018.ref020]\]. In a more recent study, the components of trophozoite ER and Golgi apparatus were determined. About 1,500 proteins were grouped into two main classes, traffic machinery and GTPases, and about 100 markers were identified in both compartments \[[@pone.0156018.ref021]\]. Additionally, a comparison of the *E*. *histolytica* proteome with that of the related non-pathogen amoeba *E*. *dispar* has allowed the identification of peroxiredoxin and alcohol dehydrogenase 3 as proteins associated to virulence and pathogenicity \[[@pone.0156018.ref022],[@pone.0156018.ref023]\].

In contrast, only one proteomic study on the cyst stage of *E*. *histolytica* has been published to date. In that work, cysts were partially purified from five stool samples from patients infected with *E*. *histolytica* and each sample was analyzed by LC-MS/MS. In total, 417 different proteins were identified in the five samples, 95 of which were classified as stage-specific \[[@pone.0156018.ref024]\]. Although that study provided valuable information about the composition of the cyst, there are still no studies focusing on the process of encystment in *E*. *histolytica*, which could have a high impact on the disease control. Encystment of the reptilian parasite *E*. *invadens* has been used as a model for the process in *E*. *histolytica*. However, unlike *E*. *invadens* that encyst *in vitro* relatively easy \[[@pone.0156018.ref025]--[@pone.0156018.ref028]\], the stimuli capable of inducing differentiation in *E*. *histolytica* remain unknown, suggesting that the process is more complex than in the related species. Another approach to studying the encystment process in *E*. *histolytica* arose with the description of cyst-like structures (CLS) obtained from trophozoites cultured under different conditions. Thus, detergent-resistant CLS have been obtained *in vitro* by incubating trophozoites with a mixture of Mg^2+^, Mn^2+^, and Co^2+^ ions \[[@pone.0156018.ref029]\] or with enterobacteria at a high CO~2~ tension in the presence of histamine \[[@pone.0156018.ref030]\]. Moreover, chitin-like material was detected by HPLC in CLS obtained with the mixture of Mg^2+^, Mn^2+^, and Co^2+^ ions, suggesting that this treatment stimulates *E*. *histolytica* pathways related with chitin-like biosynthesis \[[@pone.0156018.ref031]\]. CLS described in a study by our research group were obtained under treatment of axenic trophozoites with 4mM hydrogen peroxide plus traces of metallic cations for 4 h \[[@pone.0156018.ref032]\]. These CLS showed features closely resembling genuine cysts, including rounded shape, size reduction, refringence, multinucleation (mainly 2 or 3 nuclei, and occasionally 4), and overexpression of glucosamine 6-phosphate isomerase, the rate-limiting enzyme in the chitin synthesis pathway \[[@pone.0156018.ref032]\]. In a subsequent study, CLS formation by hydrogen peroxide was inhibited in trophozoites in which glucosamine 6-phosphate isomerase expression was silenced by siRNA \[[@pone.0156018.ref033]\].

This study aimed to determine whether hydrogen peroxide-obtained CLS constitute an intermediate stage in the transformation of *E*. *histolytica* trophozoites into cysts, by performing a global comparison of the proteomes of *E*. *histolytica* trophozoites, cysts, and CLS obtained by LC-MS/MS. In addition to shed light on the proteomic nature of *E*. *histolytica* CLS obtained *in vitro*, this study provides new data on cyst composition, including several previously unpublished potential therapeutic and diagnostic targets.

Material and Methods {#sec002}
====================

*Entamoeba histolytica* cultures {#sec003}
--------------------------------

*E*. *histolytica* strain HM1: IMSS trophozoites were maintained in TYI-S-33 medium \[[@pone.0156018.ref034]\] supplemented with 15% adult bovine serum (Microlab), 3% vitamins (SAFC, Biosciences), and 1% antibiotic/antimycotic (Gibco) at 37°C under axenic conditions for 72 h.

Cyst-like structures (CLS) induction {#sec004}
------------------------------------

CLS induction was performed as previously reported \[[@pone.0156018.ref032]\]. Briefly, trophozoites were cultured in 50-ml bottles containing TYI-S-33 medium (approximately 5 × 10^6^ trophozoites per bottle) for 72 h and treated for 4 h with hydrogen peroxide 4 mM, 0.02 ppm of each Co, Cd, Cu, Ni, and Zn cations, and 0.01 ppm of Fe (Merck). After treatment, CLS were extensively washed with phosphate-buffered saline (PBS), pH 7.4, at 4°C, centrifuged at 150 × *g* for 5 min, resuspended in sarkosyl 0.1% in PBS, and allowed to sit for 20 min at room temperature. After three washes, the pellets of detergent-resistant CLS were processed to obtain protein extracts. In addition, aliquots of unstained and calcofluor white-stained CLS were analyzed under light and UV microscope, respectively, and used as fresh as possible in immunofluoresce experiments.

Human stool samples {#sec005}
-------------------

Human stool samples were provided by Laboratories CARPERMOR (Mexico City) following all applicable ethical protocols, including patient signed consent for sample donation. Approximately 80 samples, coprology-positive for complex *E*. *histolytica/E*.*dispar*, and as fresh as possible were processed for DNA isolation following all security measures for a biological sample level 2, as described below.

DNA purification from human stool {#sec006}
---------------------------------

The QIAamp® DNA Stool Kit (Qiagen) was used to purify DNA from human stool samples according to the supplier\'s directions. Briefly, 200 mg of each stool sample were weighed into a 2-ml microcentrifuge tube, added with 1.4 ml of ASL buffer and homogenized by vortexing. The mixture was heated for 5 min at 70°C and then homogenized and centrifuged at maximum speed for 1 min. The supernatant (approximately 1.2 ml) was placed in a new 2-ml tube and an Inhibitex tablet was added; the mixture was homogenized until dissolved and incubated for 1 min at room temperature. The tube with the mixture was centrifuged at full speed for 3 min and the supernatant (200 μl) was placed in a 1.5-ml tube containing 15 μl of proteinase K and 200 μl of AL buffer. The solution was mixed for 15 s until homogenized and incubated at 70°C for 10 min. After incubation, 200 μl of 96--100% ethanol was added, and the mixture was placed in an affinity column. The column was centrifuged at maximum speed for 1 min, washed twice with 500 μl of each AW1 and AW2 buffers, and centrifuged at maximum speed for 3 min. The column was transferred to a 1.5-ml tube, and the DNA was eluted from the column with 200 μl of AE buffer, incubated for 1 min at room temperature and centrifuged at maximum speed for 1 min. The obtained DNA was stored at --20°C until used.

*E*. *histolytica* and *E*. *dispar* differential detection by PCR {#sec007}
------------------------------------------------------------------

Since *E*. *dispar* cysts are not visually distinguishable from *E*. *histolytica* cysts, a PCR assay was performed to identify both species in DNA from the coprology-positive feces obtained as mentioned above. A common forward primer EntaF 5\'-ATG CAC GAG AGC GAA AGC AT-3' and two species specific reverse primers EhR 5\'- GAT CTA GAA ACA ATG CTT CTC T-3' and EdR, 5\'-CAC CAC TTA CTA TCC CTA CC-3', were used for *E*. *histolytica* and *E*. *dispar* identification, respectively \[[@pone.0156018.ref035]\]. PCR reactions were performed on 100 ng of purified DNA using a HotStar Taq plus Master Mix Kit (Qiagen), according to the manufacturer's directions. Reactions were run as follows: 94°C for 7 min; 35 cycles of 94°C for 90 s, annealing for 1 min; 72°C for 1 min; and final incubation at 72°C for 7 min. Annealing temperature was set to 56°C for *E*. *histolytica* and to 58°C for *E*. *dispar* specific reverse primers, respectively. Amplicons were separated in 1%-agarose gels after staining with ethidium bromide, and visualized under UV light.

Cyst isolation {#sec008}
--------------

Cysts were partially isolated from 10 stool samples positive for *E*. *histolytica* by PCR, as reported elsewhere \[[@pone.0156018.ref036]\]. Briefly, approximately 7 g of each stool sample were homogenized with 40 ml of PBS. Large particles were removed by filtering through a double-layer gauze. Filtrates were centrifuged at 150 × *g* for 7 min at 4°C; supernatants were decanted and pellets were extensively washed with PBS until supernatant was clear. Pellets were resuspended in 5 ml of distilled water. Suspensions were gently layered onto 40 ml of sucrose 1.5 M and centrifuged at 500 × *g* for 10 min at 4°C. Immediately, the cyst-containing interface was carefully removed, mixed with 20 ml of distilled water and centrifuged at 150 × *g* for 5 min at 4°C. Pellets were resuspended again in 5 ml of distilled water, layered onto 15 ml of sucrose 0.75 M, and centrifuged at 500 × *g* for 15 min at 4°C. Pellets containing cysts were stored at 4°C in PBS with sodium azide until used.

Preparation of *E*. *histolytica* trophozoite, CLS and cyst protein extracts {#sec009}
----------------------------------------------------------------------------

To obtain trophozoite total extracts, cultures of 72 h were chilled on ice for 5 min and the cells harvested by centrifugation at 150 × *g* for 5 min. Then, trophozoites were transferred to Falcon tubes and washed five times with PBS followed by centrifugation at 150 × *g* for 5 min. Pellets from trophozoite or CLS mentioned above were washed and placed in 1 ml of PBS with protease inhibitors (Complete tablet, Sigma) on ice for 15 min. Then, samples underwent 10 liquid nitrogen/37°C freeze-thaw cycles and were centrifuged at 16,000 × *g* for 30 min at 4°C. Supernatants (total protein extracts) were transferred to clean tubes, and protein concentration was determined by the Bradford method \[[@pone.0156018.ref037]\]. Extracts were aliquoted and stored at --70°C until used.

Cyst protein extract was prepared from a pool of isolated cysts (about 2 × 10^5^) from 10 PCR-positive samples for *E*. *histolytica*, as follows: cysts were washed and placed in 500 μl of PBS with protease inhibitors (Complete tablet, Sigma) on ice for 15 min. Then, samples underwent 10 liquid nitrogen/37°C freeze-thaw cycles and sonication for 30 min (15 s/15 s rest), followed by centrifugation at 16,000 × *g* for 30 min at 4°C. Supernatants (total protein extracts) were transferred to clean tubes, and protein concentration was determined by the Bradford method \[[@pone.0156018.ref037]\]. Cyst protein extract was stored at -70°C until used.

Sample preparation for LC-MS/MS analysis {#sec010}
----------------------------------------

About 40 μg of the trophozoite, CLS and cyst protein extracts were applied to 12% polyacrylamide gels and run just enough time to allow the mixture of proteins to enter the stacking gel and concentrate as a coarse band. Bands from each sample (trophozoites, cysts and CLS) were cut under sterile conditions and sent to Bioproximity Laboratories (Chantilly, VA) for LC-MS/MS analysis.

Protein denaturation and digestion {#sec011}
----------------------------------

Samples were prepared for digestion by the filter-assisted sample preparation (FASP) method \[[@pone.0156018.ref038]\]. Briefly, the samples were suspended in 2% SDS, 50 mM Tris-HCl, pH 7.6, 3 mM DTT, briefly sonicated, and incubated at 40°C for 20 min. Samples were clarified by centrifugation, and then supernatants were transferred onto 30-kDa MWCO Amicon columns (Millipore), centrifuged at 13,000 × *g* for 30 min and resuspended in 8 M urea, 100 mM Tris-HCl, pH 7.6. Proteins in the sample were then alkylated with 15 mM iodoacetamide. After diluting in 2M urea, proteins were digested overnight with trypsin at an enzyme: substrate ratio of 1:40 at 37°C with constant agitation. Digested peptides were collected by centrifugation.

Peptide desalting {#sec012}
-----------------

About 20 μg of the digested peptides were desalted using C18 STAGE stop-and-go extraction tips \[[@pone.0156018.ref039]\]. Briefly, a C18 STAGE tip was activated with methanol for each sample, and then conditioned with acetonitrile 60%:acetic acid 0.5%, followed by acetonitrile 2%/acetic acid 0.5%. Samples were loaded onto the tips and desalted with acetic acid 0.5%. Peptides were eluted with acetonitrile 60%:acetic acid 0.5% and lyophilized in a SpeedVac (Thermo Savant) apparatus to near dryness.

Liquid chromatography-tandem mass spectrometry (LC-MS/MS) {#sec013}
---------------------------------------------------------

Peptides were analyzed by LC-MS/MS. LC was performed on an Easy-nLC 1000 UHPLC system (Thermo Scientific, Waltham, MA). Mobile phase A was 97.5% MilliQ water, 2% acetonitrile, 0.5% acetic acid. Mobile phase B was 99.5% acetonitrile, 0.5% acetic acid. LC gradient ran from 0% B to 35% B over 210 min, then to 80% B for further 30 min. Samples were loaded directly into a C18 50 cm × 75 μm column (Thermo Easy Spray PepMap). LC was interfaced to a quadrupole-Orbitrap mass spectrometer (Q-Exactive, Thermo Fisher) via nano-electrospray ionization using a source with an integrated column heater (Thermo Easy Spray). The column was heated to 50°C. An electrospray voltage of 2.2 kV was applied. The mass spectrometer was programmed to acquire, by data-dependent acquisition, tandem mass spectra from the top 20 ions in the full scan from 400--1200 m/z. Dynamic exclusion was set to 15 s, single-charged ions were excluded, isolation width was set to 1.6 Da, full MS resolution to 70,000 and MS/MS resolution to 17,500. Normalized collision energy was set to 25, automatic gain control to 2e5, maximum fill MS to 20 ms, maximum fill MS/MS to 60 ms and the underfill ratio to 0.1%.

Data processing and library searching {#sec014}
-------------------------------------

Mass spectrometer RAW data files were converted to the mz5 format using the ms convert \[[@pone.0156018.ref040]\]. Briefly, all searches required 10 ppm precursor mass tolerance, 0.02 Da fragment mass tolerance, strict tryptic cleavage, 0 or 1 missed cleavages, fixed modification of cysteine alkylation, variable modification of methionine oxidation, and expectation value scores of 0.01 or lower. Proteins were required to have 1 or more unique peptides across the analyzed samples with E-value scores of 0.01 or less.

Bioinformatic analysis {#sec015}
----------------------

Proteins identified in trophozoite, cyst, and CLS total extracts were analyzed with the BioVenn software for Venn diagram construction, STATISTICA 12 for correlation analysis, and DAVID Bioinformatics Resources 6.7 for functional classification \[[@pone.0156018.ref041], [@pone.0156018.ref042]\]. The proteins identified were also mapped with Gene Ontology terms using the Panther DB \[[@pone.0156018.ref043],[@pone.0156018.ref044]\], and the overrepresentation test was performed using a *P*-value \< 0.05. Those proteins that could not be annotated using Panther were annotated with Argot2 (total score \> 200) \[[@pone.0156018.ref045]--[@pone.0156018.ref047]\]. The sub-cellular location of some proteins was predicted using CELLO v2.5 \[[@pone.0156018.ref048],[@pone.0156018.ref049]\], and antigenicity was predicted using the Kolaskar and Tongaonkar antigenicity scale \[[@pone.0156018.ref050]\].

*E*. *histolytica* trophozoites, CLS and cyst RNA purification {#sec016}
--------------------------------------------------------------

RNA was purified from trophozoites or CLS with the Direct-zol RNA MiniPrep kit (Zymo Research, Irvine, CA). Briefly, approximately 10^6^ trophozoites or CLS were added with 1 ml of Trizol and homogenized by vortexing. Subsequently, 1 ml of ethanol was added, and the homogenate was vortexed and placed on a Zymo-Spin IIC Column and centrifuged for 1 min at maximum speed. Then, the column was treated with 400 μl of RNA Pre Wash and washed with 700 μl of RNA Wash buffer, and then centrifuged for 1 min at maximum speed. Finally, the column was transferred to an Eppendorf tube and RNA was eluted with 50 μl of RNase-free water. RNA was quantified and stored at --70°C until used.

Cyst RNA was purified from the 0.25 g of sample stool with the Power Microbiome RNA isolation kit (MO BIO Laboratories, Carlsbad, CA) following the manufacturer\'s directions. Briefly, stool was placed into a 1-ml tube; 650 μl of PM1 were added; the tube was vortexed for 10 min and centrifuged at maximum speed for 1 min. The supernatant was transferred into a new tube, 150 μl of PM2 solution were added, and the mixture was centrifuged for 1 min. The supernatant was collected into a new tube and 650 μl of PM3 and PM4 solutions were added. Then, 650 μl of supernatant were loaded onto a Spin Filter and centrifuged for 1 min; 650 μl of PM5 Solution were added and the Spin Filter was centrifuged for 1 min. Then, 50 μl of DNase I Solution and 400 μl of PM7 Solution were added to the Spin Filter and it was centrifuged for 1 min. The column was washed with PM5 and PM4 solutions and centrifuged for 1 min after each wash. Finally, RNA was eluted with 50 μl of RNase-free water. RNA was quantified and stored at --70°C until used.

Reverse transcriptase PCR {#sec017}
-------------------------

RT-PCR was performed using the SuperScript One-Step RT-PCR kit with Platinum Taq (Invitrogen, Carlsbad, CA) following the manufacturer's specifications. Reactions were run using 200 ng of RNA from each sample. Samples were amplified as follows: 55°C for 30 min; 94°C for 2 min; 40 cycles of 94°C for 15 s; annealing for 30 s; 70°C for 1 min; and final incubation at 68°C for 10 min. Annealing temperature and the primers used are summarized in [Table 1](#pone.0156018.t001){ref-type="table"}. Amplicons were resolved in 1% agarose gels for visualization.

10.1371/journal.pone.0156018.t001

###### Oligonucleotides used for RT-PCR of *Entamoeba histolytica* cyst wall proteins.

![](pone.0156018.t001){#pone.0156018.t001g}

  Sequence Accession   Protein name                                         Primers F/R 5' -3'                                                     Amplified size   Annealing T ° C
  -------------------- ---------------------------------------------------- ---------------------------------------------------------------------- ---------------- -----------------
  XM_001913371.1       Malic enzyme, putative                               ACTCGGATCCATGGCACAATTAAAAGCAGATTCCTCGAGTTTTCCAGTGACTTTGTTAA            1464             52
  XM_645281.2          fructose-1,6-bisphosphate aldolase, putative         ACTCGGATCCATGGCTGCTAAGACTGTTAACATTCCTCGAGATACCATGATTTTCCTGCTGAG        990              61
  XM_645264.2          glyceraldehyde-3-phosphate dehydrogenase, putative   ACTCGGATCCATGTCAATTAAGGTCGGTATTAATTCCTCGAGATGAACTTTAGAAATGATTTGGA      1000             58
  XM_001914290.1       Gal/GalNAc (Fragment LC3)                            TAGAAAGCTTATGTTCTAGTTTAACATGTCCATTTTTCTAGATTAACATGTTTTCTTTGTGTAAATAG   1028             59
  XM_001914339.1       Peroxiredoxin                                        ACTCGGATCCATGTCTTGCAATCAACAAAAAGATTCCTCGAGTCTTGTTTGTTTTAATGTTGTTAA     711              58
  AF401986             Chitinase Jessie 1                                   AAGTGGATCCATGACACTAATTATTTTCTTACCAAGCTTTTATTTATAATTTTCATAAA            273              63
  AF401987             Chitinase Jessie 2                                   AAGTGGATCCATGATGATATTAATCATTTTACCAAGCTTTTAACAATAATCATCATTT             294              65
  AF401988             Chitinase Jessie 3                                   AAGTGAATTCATGAAATTAGCTGTTTTAATACCAAGCTTTTATTTTGAATAATGAACT             1800             65
  AF401984.1           Lectin Jacob                                         AAGTGGATCCATGAAAGCATTACTTGTTATCCCAAGCTTTTAATAACATGGATTGTTA             456              66
  XM_652120.2          Chitin Synthase 2,putative                           AAGTGGATCCATGTCAGTGAGTTTCCTTATCCCAAGCTTTTACTCTGAATGAGAAAGG             2841             68
  AF082517             ADP-ribosylation factor (ARF)                        GTAGGACTTGATGCGTGAAGAATTAATGA                                          259              51

Western Blot against Jacob protein {#sec018}
----------------------------------

A Western blot was performed to identify the Jacob protein in CLS and cysts. 15 μg of each sample were resolved in a 12% acrylamide gel and then transferred to a PVDF membrane. The membrane was blocked with milk 10% for 1 h at 37°C. Anti-Jacob 1:1000 (kindly donated by Dr. W.A. Petri Jr.) incubated overnight at 4°C and a goat HRP-conjugated anti-rabbit 1:50,000 (62--6120 ZYMED, San Francisco, CA) incubated for 2 h at 37°C, were used as primary and secondary antibodies, respectively. The Immune complex in the membrane was developed with the Super Signal West Femto Maximum Sensitivity Substrate kit (Thermo Scientific). Extract from trophozoites was used as a negative control.

Immunofluorescence against Jacob protein {#sec019}
----------------------------------------

CLS and cysts were fixed with paraformaldehyde 4% for 30 min at room temperature. Then, samples were washed three times with PBS and permeabilized with Triton 1% for 1 h at 50°C. Samples were blocked with BSA 1% for 1 h, and treated with the anti-Jacob 1:200 incubated overnight at 4°C and goat FITC-conjugated anti-rabbit 1:200 (F1262, Sigma, St. Louis, MO) incubated for 2 h at 37°C, were used as primary and secondary antibodies, respectively. Samples were immediately visualized under a fluorescence microscope. Trophozoites processed in parallel were used as a negative control.

Results {#sec020}
=======

CLS and cyst selection for the study {#sec021}
------------------------------------

CLS were obtained after a 4-h treatment with hydrogen peroxide 4 mM as previously reported \[[@pone.0156018.ref032]\]. After detergent resistance selection with sarkosyl 0.1% for 20 min, the morphology of the obtained structures was verified by microscopy. CLS showed a rounded shape, size reduction, and refringence that resemble cysts isolated from fecal samples ([Fig 1A](#pone.0156018.g001){ref-type="fig"}). In addition, the cover of CLS was strongly stained with calcofluor white ([Fig 1A](#pone.0156018.g001){ref-type="fig"}); previous studies using CFDA showed that CLS are still viable at this time of treatment \[[@pone.0156018.ref032]\]. On the other hand, 10 stool samples were selected by PCR as uniquely positive for *E*. *histolytica* (\~100 bp band) from 80 putatively positive amoeba samples as determined by coproparasitoscopic analysis. The other 70 samples were excluded from this study because they were either positive by PCR for *E*. *dispar* (\~700 bp band) or negative for both amoeba species. In [Fig 1B](#pone.0156018.g001){ref-type="fig"}, a representative agarose gel with 4 samples analyzed by PCR is shows.

![CLS induction and stool samples positive for *E*. *histolytica*.\
A) Samples used in this study. From left to right: *E*. *histolytica* trophozoites, CLS (induced from trophozoites after a 4 h treatment with H~2~O~2~ 4 mM), CLS stained with calcofluor white and a cysts partially purified from a fecal sample and stained with Lugol. B) Representative agarose gel of the PCR products differentiating *E*. *histolytica* from *E*. *dispar*. Samples 1 and 4 were positive to *E*. *dispar*, sample 3 to *E*. *histolytica* and sample 2 negative. *E*. *histolytica* and *E*. *dispar* trophozoite DNA were used as positive controls (Eh+ and Ed+).](pone.0156018.g001){#pone.0156018.g001}

Comparison of *E*. *histolytica* trophozoites, cysts and CLS proteomic data {#sec022}
---------------------------------------------------------------------------

Raw protein extracts from trophozoites, CLS, and cysts were analyzed by mass spectrometry. In total, 1990 proteins were identified: 1029 in trophozoites, 550 in CLS, and 411 in cysts ([Fig 2A](#pone.0156018.g002){ref-type="fig"}). However, only 1419 *E*. *histolytica* proteins were identified as different ([S1 Table](#pone.0156018.s001){ref-type="supplementary-material"}). This represents about 14% of the theoretical proteome of the parasite based on 9,938 predicted genes \[[@pone.0156018.ref051], [@pone.0156018.ref052]\]. Among the 1029 proteins identified in trophozoites, 789 are annotated and 240 are hypothetical proteins (23%). Out of the 550 proteins identified in CLS, 443 are annotated and 107 are hypothetical (19%), whereas out of the 411 proteins identified in cysts 250 are annotated and 161 proteins are hypothetical (almost 40%) ([Fig 2B](#pone.0156018.g002){ref-type="fig"}). The number of proteins identified in trophozoites was roughly the double of those found in cysts and CLS. About 25% of all proteins identified in this study are hypothetical or have not been characterized yet (All proteomic data have been deposited in the Proteome Xchange database under Accession No. PXD004030).

![Comparison of proteomic data obtained from *E*. *histolytica* trophozoites, cysts and CLS.\
A) Proteome comparison using the BioVenn software. B) Percentage of annotated and hypothetical proteins identified in each sample. C) Global protein association between samples, labeled as total, annotated, or hypothetical proteins as determined by correlation test. R-values closer to 1 indicate a closer association. T: Trophozoite; CLS: cyst-like structure; C: cyst.](pone.0156018.g002){#pone.0156018.g002}

A comparison of the three proteomes showed that only 74 proteins are shared among trophozoites, cysts, and CLS ([Fig 2A](#pone.0156018.g002){ref-type="fig"} and [Table 2](#pone.0156018.t002){ref-type="table"}). Additionally, 385 proteins are shared by trophozoites and CLS, whereas 31 proteins are shared by trophozoites and cysts. Only 7 proteins are shared between cysts and CLS. The analysis also showed 539, 299, and 84 proteins unique to trophozoites, cysts, and CLS samples, respectively. Therefore, based on the numbers of different proteins either shared or unique to each sample, CLS seem more akin to trophozoites than to cysts. To verify this, a statistical correlation test comparing all proteins identified in the three samples was performed. The results showed that CLS are more closely related to trophozoites than to cysts (*R* = 0.9 vs. 0.7, respectively; [Fig 2C](#pone.0156018.g002){ref-type="fig"}, black bars). It is noteworthy that when proteins were grouped as annotated or hypothetical, very low association levels were found between hypothetical proteins in trophozoites and CLS with respect to cysts (0.03 and 0.05, respectively; [Fig 2C](#pone.0156018.g002){ref-type="fig"}, gray bars).

10.1371/journal.pone.0156018.t002

###### Proteins shared among trophozoites, cysts, and CLS as identified by LC-MS/MS.

![](pone.0156018.t002){#pone.0156018.t002g}

  ID Accesion Uniprot   Name                                                         No. of matched peptides /Count peptide Hits             
  --------------------- ------------------------------------------------------------ --------------------------------------------- --------- ------------
  S0AUW6                Actin                                                        97/645                                        10/68     46/373
  S0AWJ4                Actin, putative                                              100/645                                       10/68     45/358
  S0AWF4                Actin                                                        96/640                                        10/68     45/363
  S0AWZ1                Actin                                                        100/639                                       10/68     46363
  S0AWJ9                Actin, putative                                              94/635                                        10/68     45/363
  S0AUT4                Actin, putative                                              97/626                                        10/68     44/361
  S0AUS7                Actin, putative                                              95/616                                        9/64      43/354
  S0AVA7                Actin, putative                                              94/608                                        9/66      44/361
  S0AWA2                Actin, putative                                              91/605                                        10/68     40/331
  S0AXB5                Actin, putative                                              83/596                                        11/70     40/331
  **Q24801**            **Pyruvate phosphate dikinase**                              **113/587**                                   **2/4**   **64/285**
  S0AV75                Actin, putative                                              92/586                                        10/68     45/346
  Q9TYD6                Actin                                                        96/583                                        10/68     43/342
  S0AUR6                Actin, putative                                              90/583                                        9/64      40/332
  S0AV23                Actin, putative                                              87/579                                        8/51      43/324
  S0AVQ9                Actin, putative                                              90/568                                        10/68     46/337
  S0AWT4                Actin, putative                                              74/536                                        8/63      34/396
  B1N621                Actin, putative                                              79/487                                        9/66      38/282
  S0AW09                Actin, putative                                              86/478                                        8/35      40/285
  S0AV15                Actin, putative                                              75/444                                        8/38      38/280
  S0AVT2                Actin, putative                                              66/421                                        7/50      35/251
  **C4LVR9**            **Glyceraldehyde-3-phosphate dehydrogenase**                 **71/333**                                    **1/2**   **30/105**
  **S0AX11**            **Glyceraldehyde-3-phosphate dehydrogenase**                 **69/330**                                    **1/2**   **30/105**
  S0AYM0                Actin, putative                                              80/316                                        3/19      32/148
  S0B0T0                Actin, putative                                              73/282                                        2/15      30/133
  S0B1Y3                Actin                                                        73/276                                        2/15      29/116
  C4LU72                Myosin heavy chain                                           100/226                                       1/1       37/73
  Q07569                Myosin heavy chain                                           83/197                                        1/1       31/65
  B1N306                Elongation factor 2                                          69/195                                        1/1       12/28
  **B1N2J0**            **Malic enzyme, putative**                                   **52/185**                                    **2/5**   **20/51**
  C4LY85                Ubiquitin, putative                                          11/176                                        1/1       4/16
  **G5EKL5**            **Malic enzyme**                                             **48/174**                                    **2/5**   **18/45**
  **S0AW44**            **Malic enzyme, putative**                                   **46/172**                                    **2/5**   **18/48**
  **S0AZU7**            **Phosphoglycerate kinase**                                  **33/156**                                    **1/1**   **15/45**
  S0AWG4                Elongation factor 1-α                                        38/150                                        1/3       21/86
  **C4M3S5**            **Heat shock protein 70, putative**                          **45/150**                                    **2/5**   **19/54**
  O15593                Actin                                                        23/136                                        1/2       5/60
  **C4LXD7**            **Fructose-1,6-bisphosphate aldolase, putative**             **45/133**                                    **2/3**   **16/36**
  S0B0R7                Elongation factor 1-α                                        33/117                                        1/3       18/72
  **C4M3Q0**            **Peroxiredoxin**                                            **31/98**                                     **1/4**   **27/124**
  **C4MB38**            **Protein disulfide isomerase, putative**                    **29/93**                                     **1/1**   **35/180**
  **Q24835**            **Galactose-specific adhesin 170kD subunit**                 **35/91**                                     **1/1**   **54/160**
  **B1N3C7**            **Galactose-inhibitable lectin 170 kDa subunit, putative**   **33/90**                                     **1/1**   **55/166**
  **B1N5A8**            **Peroxiredoxin**                                            **26/90**                                     **1/4**   **23/116**
  O15729                Peptidyl-prolyl cis-trans isomerase                          16/89                                         1/1       5/13
  **C4LTM0**            **Gal/GalNAc lectin heavy subunit**                          **29/81**                                     **1/1**   **50/153**
  **B1N486**            **Heat shock protein 70, putative**                          **29/69**                                     **2/5**   **9/28**
  C4LYJ7                Galactokinase, putative                                      21/61                                         1/2       10/30
  **C4M770**            **70 kDa heat shock protein, putative**                      **24/59**                                     **2/2**   **43/177**
  O15601                Elongation factor 1α                                         12/55                                         1/3       8/26
  **O77164**            **70 kDa heat shock protein Hsp70-Bip**                      **21/50**                                     **2/2**   **37/142**
  C4M0F4                14-3-3 protein 3                                             18/47                                         1/4       5/11
  C4LVD3                Sulfate adenylyltransferase, putative                        20/43                                         2/2       6/11
  C4M6Y2                Polyadenylate-binding protein, putative                      16/28                                         1/1       3/5
  B1N336                40S ribosomal protein S4, putative                           11/27                                         1/1       1/2
  B1N368                Putative uncharacterized protein                             14/26                                         1/1       2/4
  C4M711                Putative uncharacterized protein                             9/26                                          1/1       2/2
  C4M9P2                Filopodin, putative                                          11/21                                         1/1       6/9
  **C4MBE2**            **EF-hand calcium-binding domain containing protein**        **6/17**                                      **1/4**   **8/72**
  Q9BLE4                Small GTPase Rab11B                                          9/17                                          1/1       6/7
  Q24834                Disulphide oxidoreductase                                    6/16                                          1/1       3/4
  Q9BLE8                Small GTPase Rab7A                                           4/14                                          2/2       2/4
  C4M6S2                60S ribosomal protein L14, putative                          5/13                                          1/2       2/3
  C4M8Z5                Putative uncharacterized protein                             6/12                                          1/1       1/1
  Q6AW60                EhRab11A protein                                             6/11                                          1/1       5/6
  C4M846                26s protease regulatory subunit                              6/10                                          1/1       2/2
  C4LYV2                60S ribosomal protein L7, putative                           6/9                                           1/1       1/2
  C4LXG1                Purine nucleoside phosphorylase, putative                    3/7                                           1/1       1/2
  C4M7T9                Ubiquitin-activating enzyme, putative                        4/6                                           1/3       2/4
  B1N384                60S ribosomal protein L4, putative                           2/5                                           1/1       1/2
  C4M3X0                Calcium-transporting ATPase                                  3/5                                           2/3       2/3
  Q27642                Calcium-transporting ATPase                                  2/4                                           1/1       2/3
  C4LYN0                Putative uncharacterized protein                             2/2                                           1/1       4/9
  C4M0V2                Multidrug resistance protein, putative                       1/1                                           1/1       1/3

Proteins in bold are discussed in the text

The results show that the differences in trophozoites and CLS from cysts are largely based on hypothetical proteins when the presence or absence of proteins, rather than their relative abundance, is considered. This is interesting in the sense that hypothetical proteins in *E*. *histolytica* cysts could be important for the generation and/or maintenance of this stage. When the group of 74 proteins shared by the three samples was compared on the basis of relative abundance (peptide-hit score), 24 actin entries showed the highest peptide-hit score in all three samples. It is remarkable that peptide-hits for cellular metabolism proteins like pyruvate phosphate dikinase, glyceraldehyde 3-phosphate dehydrogenase, malic enzyme, phosphoglycerate kinase, fructose 1,6-bisphosphate aldolase, and galactokinase were more than double in trophozoites than in CLS and cysts ([Table 2](#pone.0156018.t002){ref-type="table"}). In contrast, peptide-hit score was higher, in some cases two or three times higher, for oxidative stress enzymes like peroxiredoxin and two HSP70 (Bip and a putative one), as well as for disulfide isomerase and EF-hand calcium-binding domain-containing proteins in CLS samples than in trophozoites and cysts. It is worth mentioning the high expression in CLS of the 170-kDa heavy subunit of galactose-inhibitable lectin, given its role in cyst wall formation in *E*. *invadens* \[[@pone.0156018.ref053]\]. Finally, in cysts, the abundance of malic enzyme, putative 70-kDa heat shock proteins, and a 14-3-3 protein was relatively high, in addition to actins ([Table 2](#pone.0156018.t002){ref-type="table"}).

As mentioned above, hundreds of unique proteins were identified in trophozoite and cyst samples, whereas CLS shared most proteins with trophozoites. Unique proteins with a high peptide-hit score may be stage-specific and might play a functional role. A list of the 15 top highly abundant, unique proteins of each sample and their possible function is shown in [Table 3](#pone.0156018.t003){ref-type="table"}. Proteins involved in DNA-binding, translation, ribosome biogenesis, and actin polymerization were identified as relatively abundant in trophozoites. Grainin, a granule calcium-binding protein probably involved in control of endocytotic pathways and granule discharge, was identified in CLS with the highest peptide-hits score. Other unique proteins involved in proton transport, proteolysis, and redox homeostasis and stress response were also identified. In contrast, cysts showed high expression levels of many putative uncharacterized proteins (8 out 15 proteins with the highest peptide-hit score) in addition to a putative nuclear transcription factor, an aminoglycoside 3'-phosphotransferase, and an alkyl sulfatase.

10.1371/journal.pone.0156018.t003

###### Proteins identified as unique with highest peptide-hit score in trophozoites, CLS, and cysts.
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  Accession number   Protein name                                         No. of matched peptides/ Count peptides   Function
  ------------------ ---------------------------------------------------- ----------------------------------------- ---------------------------------------------------
  **Trophozoites**                                                                                                  
  C4LV11             Putative uncharacterized protein                     17/35                                     **unknown function**
  C4LWJ6             LIM zinc finger domain containing protein            9/32                                      *zinc ion binding*
  C4LV07             Malate dehydrogenase, putative                       7/30                                      *oxidoreductase activity*
  C4LT49             40S ribosomal protein S24, putative                  11/29                                     **translation**
  B1N3R9             60S ribosomal protein L7a, putative                  10/27                                     **ribosome biogenesis**
  C4M0A8             Putative uncharacterized protein                     16/26                                     **unknown function**
  C4M0Q2             40S ribosomal protein S8                             12/24                                     **translation**
  C4M727             60S ribosomal protein L27, putative                  11/24                                     **translation**
  C4LUC7             Non-conventional myosin IB                           11/23                                     *ATP binding*
  C4LW30             RNA modification enzymes, MiaB-family                12/23                                     **RNA modification**
  C4LZB0             40S ribosomal protein S6                             8/23                                      **translation**
  C4M7H1             Actobindin, putative                                 10/23                                     **binds actin monomers**
  C4LZ12             Tyrosyl-tRNA synthetase, putative                    9/22                                      **tRNA aminoacylation for protein translation**
  B1N2Z3             60S acidic ribosomal protein P0, putative            10/21                                     **ribosome biogenesis**
  C4LSV0             ARP2/3 complex 20 kDa subunit, putative              10/21                                     **actin filament polymerization**
  **CLS**                                                                                                           
  B1N4A1             Grainin, putative                                    9/22                                      *calcium ion binding*
  C4M784             Putative uncharacterized protein                     10/18                                     *catalytic activity*
  C4LTM6             Serine-threonine-isoleucine rich protein, putative   8/15                                      **integral component of membrane**
  C4LU65             Vacuolar ATP synthase subunit H, putative            6/14                                      **ATP hydrolysis coupled proton transport**
  B1N330             Serine-threonine-isoleucine rich protein, putative   6/11                                      **integral component of membrane**
  C4LU31             Thioredoxin, putative                                4/8                                       **cell redox homeostasis**
  C4LUQ2             Glucosidase, putative                                3/6                                       **carbohydrate metabolic process**
  C4LTT0             Cysteine proteinase, putative                        3/6                                       *cysteine-type peptidase activity*
  C4LTV9             Uncharacterized protein                              3/5                                       **unknown function**
  C4LV34             Putative uncharacterized protein                     2/5                                       **unknown function**
  C4LT65             Heat shock protein 70, putative                      1/4                                       **Stress response**
  C4M916             Copine, putative                                     2/4                                       *calcium-dependent membrane binding proteins*
  C4LX23             RhoGAP domain containing protein                     2/4                                       **signal transduction**
  C4M6M0             Putative uncharacterized protein                     1/4                                       **small GTPase mediated signal transduction**
  C4M741             Cortexillin, putative                                2/4                                       **Cytokinesis**
  **Cyst**                                                                                                          
  C4M4Q8             Nuclear transcription factor, putative               1/29                                      *sequence-specific DNA binding*
  C4M6B9             Putative uncharacterized protein                     1/23                                      *RNA binding*
  B1N624             Aminoglycoside 3\'-phosphotransferase, putative      4/16                                      **response to antibiotic**
  C4M8Z0             Alkyl sulfatase, putative                            1/15                                      *alkyl sulphatase* activity
  C4MBE9             Putative uncharacterized protein                     2/12                                      **unknown function**
  C4M1F3             Putative uncharacterized protein                     1/11                                      **unknown function**
  C4M977             Putative uncharacterized protein                     1/11                                      **rRNA processing**
  C4LW71             DNA mismatch repair protein PMS1, putative           1/7                                       **mismatch repair**
  C4LX70             Putative uncharacterized protein                     1/5                                       **double-strand break repair via non-homologous**
  C4M4W5             Putative uncharacterized protein                     1/5                                       **unknown function**
  C4LYB9             Putative uncharacterized protein                     1/4                                       **unknown function**
  C4M2G7             Putative uncharacterized protein                     1/4                                       *phosphoric ester hydrolase activity*
  B1N3D1             Tyrosine-protein kinase 2, putative                  1/3                                       *ATP binding*
  B9U2P3             Organellar DNA polymerase 1                          2/3                                       **DNA replication**
  C4LV85             Centromeric protein E, putative                      2/3                                       **kinesin-like motor protein**

Molecular function shown in italics. Biological function shown in bold. Unknown function: Unknown function in *E*. *histolytica*.

Predictions of functional analysis of the annotated proteins (approximately 75% of all identified proteins) using the bioinformatics tool DAVID was performed \[[@pone.0156018.ref042]\]. Trophozoite, CLS, and cyst proteins were grouped into different functional groups, with trophozoites showing more functional protein groups than CLS or cysts. Trophozoite proteins were mainly grouped in clusters of translation (40%), proteolysis (15%), phosphorylation (12%), and signal transduction and amino acid activation processes (10%) ([Fig 3](#pone.0156018.g003){ref-type="fig"}, white bars). CLS proteins showed a pattern quite similar to trophozoites, with translation, proteolysis, and signal transduction clusters grouping over 50% of proteins, and with percentages close to those observed in trophozoites ([Fig 3](#pone.0156018.g003){ref-type="fig"}, gray bars). Phosphorylation, signal transduction and, notably, non-membrane bounded organelle clusters included around 60% of cyst proteins.

![Functional classification of proteins identified in trophozoites, cysts, and CLS total extracts.\
The number of proteins (left y-axis) in each of 19 functional groups is shown.](pone.0156018.g003){#pone.0156018.g003}

The functional categories that are either shared or unique among samples are shown in [Fig 4](#pone.0156018.g004){ref-type="fig"}. In total, 12 categories were shared by the three samples, including metabolic, transport, and localization processes. Trophozoites and cysts shared three functional categories, while trophozoites and CLS shared eight categories. It is important to mention that cysts and CLS failed to share any functional categories. Furthermore, trophozoites, CLS, and cysts have 8, 1 and 11 unique categories.

![Comparison of functional categories among trophozoites, CLS and cysts.\
A functional comparison among the three cell types is represented in a Venn diagram. Intersections show shared functions among the analyzed samples.](pone.0156018.g004){#pone.0156018.g004}

An overrepresentation test was performed using PANTHER \[[@pone.0156018.ref043],[@pone.0156018.ref044]\] to determine the biological processes that were enriched in each analyzed sample. Several processes were identified as enriched in trophozoites (*P* \< 0.001): a sulfur compound metabolic process, respiratory electron transport chain, generation of precursor metabolites and energy, translation and monosaccharide metabolic processes. Confirming the high identity of CLS with trophozoites, an over-expression related to homologous processes in the former was also identified in the latter, except for the sulfur compound metabolic process. Furthermore, enrichment was also observed in other CLS processes such as proteolysis and protein folding (*P* \< 0.001). Finally, the most enriched processes in cysts were phagocytosis, fatty acid metabolic processes, endocytosis, cellular component movement, and organelle organization (*P* \< 0.001). It is noteworthy that translation and metabolism processes aren't enriched in cysts. The complete enrichment analysis is shown in [S2 Table](#pone.0156018.s002){ref-type="supplementary-material"}.

Validation of proteins identified in proteomic study by RT-PCR {#sec023}
--------------------------------------------------------------

Five proteins were selected to validate the proteomic findings in our study. Three proteins that were identified as less abundant in CLS with respect to trophozoites (malic enzyme, fructose 1,6-bisphosphate aldolase, and glyceraldehyde 3-phosphate dehydrogenase \[GAPDH\]), and two proteins more abundant in CLS than in trophozoites (peroxiredoxin, associated with oxidative stress response, and the Gal/GalNac lectin, associated to encystment). In agreement with the proteomic results, the RT-PCR showed that malic enzyme and fructose 1,6-bisphosphate aldolase were not expressed in CLS, in contrast with trophozoites where the expression was clearly detected ([Fig 5](#pone.0156018.g005){ref-type="fig"}). However, GAPDH showed similar expression levels in CLS and trophozoites. On the other hand, peroxiredoxin mRNA expression was observed in CLS but not in trophozoites, and the Gal/GalNAc lectin (fragment LC3 of the heavy chain) showed a 2-fold increase in CLS with respect to trophozoites ([Fig 5](#pone.0156018.g005){ref-type="fig"}), in accordance with the proteomic results. The ADP-ribosylation factor, used as internal control, was expressed at similar level in both samples. Unfortunately, we were unable to amplify the mRNA of none of the tested genes for validation in cyst RNA, although we amplified *E*. *histolytica* ribosomal RNA genes in that sample, suggesting that the messenger was present and intact (data not shown). The reason for the lack of amplification is unknown, but it could be related with the low concentration of *E*. *histolytica* cyst mRNA in the sample due to contamination with other components in stool, or to an arrest in RNA production because cyst is a metabolically inactive stage (latency stage). However, ribosomal RNA would be amplified because it is the most abundant RNA form in a cell. Oligonucleotides used in this study are shown in [Table 1](#pone.0156018.t001){ref-type="table"}.

![Validation of proteins identified by RT-PCR.\
Five proteins were selected for RT-PCR validation. Left above: malic enzyme. Left middle: F1-6BA, fructose 1,6-bisphosphate aldolase. Left below: GAPDH: glyceraldehyde 3-phosphate dehydrogenase. Right above: Gal/GalNAc lectin LC3 fragment. Right middle: peroxiredoxin. Right below: ARF, ADP-ribosylation factor, used as loading control. T: trophozoite, CLS: cyst-like structure.](pone.0156018.g005){#pone.0156018.g005}

Expression analysis of cyst wall proteins in CLS {#sec024}
------------------------------------------------

Even though our results indicate that CLS resemble more trophozoites than cysts, previous studies in our group showed that CLS exhibit some morphological and structural characteristics of cysts, including multinucleation and a detergent-resistant wall susceptible to calcofluor-white staining \[[@pone.0156018.ref032]\]. In addition, CLS overexpress glucosamine 6-phosphate isomerase, the rate-limiting enzyme of the chitin synthesis pathway, suggesting an activation of the chitin formation route in CLS. However, except for the 170-kDa Gal-lectin subunit, other structural cyst wall proteins expected to be present in *E*. *histolytica* cysts were not identified in the current proteomic analysis, neither in CLS nor in cysts. Thus, the expression of genes encoding for some of these proteins was evaluated by semi-quantitative RT-PCR using *E*. *histolytica* specific primers for Jessie 1, 2, and 3; the Jacob protein; and chitin synthase. The ADP-ribosylation factor was included as a loading control. Primers used in this study are shown in [Table 1](#pone.0156018.t001){ref-type="table"}.

Our results showed the expression of the cyst wall proteins Jessie 1, Jessie 3, and Jacob in CLS, whereas only the Jacob protein mRNA was detected in trophozoites. Although CLS have a detergent-resistant wall suggesting the presence of chitin, no chitin synthase expression was detected in that stage ([Fig 6](#pone.0156018.g006){ref-type="fig"}). As mentioned above, we were unable to amplify mRNA from none of the tested genes in cyst RNA.

![RT-PCR of transcripts encoding for cyst wall proteins in trophozoites and CLS.\
RNA was isolated from trophozoites and CLS samples and used to perform a RT-PCR for a number of cyst wall specific proteins: Jessie 1 (J1), Jessie 2 (J2), Jessie 3 (J3), Jacob, and chitin synthase (CS). RT-PCR of the ADP-ribosylation factor (ARF) was used as an internal control. Odd numbers: trophozoites samples; even numbers: CLS samples.](pone.0156018.g006){#pone.0156018.g006}

Jacob protein expression in CLS {#sec025}
-------------------------------

To determine whether the Jacob protein, previously reported in *E*. *histolytica* cyst wall \[[@pone.0156018.ref024]\], is expressed in CLS, a Western blot of CLS extracts and immunofluorescence on CLS were performed. A clear unique band of \~32 kDa was identified in CLS extracts, whereas a unique band of \~62 kDa was identified in cysts extracts ([Fig 7A](#pone.0156018.g007){ref-type="fig"}). This difference could correspond to different isoforms of the Jacob protein, being previously reported as highly polymorphic in cultured amoebas and clinical isolates and showing multiple posttranslational modifications \[[@pone.0156018.ref054], [@pone.0156018.ref055]\]. Furthermore, the Jacob protein was also detected in CLS surface by immunofluorescence, although with less intensity than the signal obtained in cysts ([Fig 7B](#pone.0156018.g007){ref-type="fig"}). This result suggests that this cyst wall protein is expressed in CLS, but as a different isoform to that expressed in cysts.

![Jacob protein expression in CLS and cyst.\
A)15 μg of sample protein were resolved on 12% acrylamide gel (Coomassie blue-stained) and transferred to a PVDF membrane. Anti-Jacob 1:1000 and a goat HRP-conjugated anti-rabbit 1:50,000 antibodies were used. Unique bands of around 30-kDa and 62-kDa were observed in CLS and cyst samples, respectively, but not in a trophozoites sample. T: Trophozoite, CLS: Cyst-like structure, C: Cyst. B) Immunofluorescence on fixed and permeabilized cyst and CLS using anti-Jacob 1:200 and a goat FITC-conjugated anti-rabbit 1:200 antibodies.](pone.0156018.g007){#pone.0156018.g007}

Analysis of cyst proteome {#sec026}
-------------------------

In 2012, Ali *et al*. published the first and to date only *E*. *histolytica* cyst proteome, using fecal samples from Indian patients \[[@pone.0156018.ref024]\]. To contribute to the incipient knowledge of this essential stage, our proteomic results were compared with the previously published data. While a similar number of proteins were identified in both studies (417 against 411proteins), only 16 proteins regarded as stage-specific were shared by cysts in both studies ([Table 4](#pone.0156018.t004){ref-type="table"}). Therefore, the sub-cellular location of these 16 proteins using CELLO v2.5 \[[@pone.0156018.ref048],[@pone.0156018.ref049]\] and their antigenicity using the Kolaskar and Tongaonkar antigenicity scale \[[@pone.0156018.ref050]\] were herein predicted. Our results showed 9 proteins with nuclear localization, three proteins located in the cytoplasm, two in the plasma membrane, and two with both nuclear and plasma membrane locations. Noticeably, three out the four of plasma membrane proteins presented an antigenicity score \> 60%, and two of them have transmembrane regions. These proteins could be considered previously undescribed *E*. *histolytica* cyst-based therapeutic and diagnostic targets and deserve further studies ([Table 4](#pone.0156018.t004){ref-type="table"}, grey labels).

10.1371/journal.pone.0156018.t004

###### Proteins identified in cysts in both studies.
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  Gene name       ID Uniprot   Name                                                              Sucellular localization           \% Antigenicity
  --------------- ------------ ----------------------------------------------------------------- --------------------------------- -----------------
  EH_113570       C4M9W2       Kinesin-like protein                                              Nuclear                           43.17
  **EH_056650**   **C4M9T0**   **Serine/threonine-protein phosphatase**                          **Plasma membrane**               **57.17**
  EH_103530       C4LVJ7       DNA primase                                                       Nuclear                           56.31
  EH_110170       C4LU71       Ubiquitin carboxyl-terminal hydrolase domain containing protein   Nuclear                           53.38
  **EH_086140**   **C4M369**   **Ras guanine Nucleotide Exchange factor, putative**              **Plasma membrane**               **63.52**
  EH_094140       C4LYK1       Rab GTPase activating protein, putative                           Nuclear                           63.29
  EH_004750       C4M071       Signal recognition particle protein SRP54, putative               Cytoplasm                         42.0
  **EH_134750**   **C4M024**   **Protein tyrosine domain-containing protein**                    **Plasma membrane and Nuclear**   **61.6**
  EH_152390       C4LSS6       Protein kinase domain containing protein                          Nuclear                           63.68
  EH_164910       C4M1Y4       Serine/threonine-protein kinase, putative                         Nuclear                           50.34
  EH_010740       C4LYW1       Putative uncharacterized protein                                  Nuclear                           56.91
  EH_031640       C4MBA2       Putative uncharacterized protein                                  Cytoplasm                         54.2
  EH_123250       C4MAL5       Putative uncharacterized protein                                  Nuclear                           33.7
  **EH_146970**   **C4M8S8**   **Putative uncharacterized protein**                              **Plasma membrane and Nuclear**   **63.58**
  EH_148300       C4LT00       Putative uncharacterized protein                                  Nuclear                           48.65
  EH_193490       C4M4V1       Haloacid dehalogenase-like hydrolase domain-containing protein    Cytoplasm                         56.19

Proteins are shown in bold with plasma membrane localization (potential therapeutic targets)

As mentioned above, about 40% of all identified cyst proteins were grouped as hypothetical proteins, roughly the double of proteins identified in the same category for trophozoites and CLS ([Fig 2B](#pone.0156018.g002){ref-type="fig"}). In order to further characterize those cyst proteins, all 161 hypothetical proteins were categorized using Argot2 bioinformatics tool \[[@pone.0156018.ref045]--[@pone.0156018.ref047]\]. Theoretical functional categories with three or more proteins, both biological and molecular, are shown in [Table 5](#pone.0156018.t005){ref-type="table"}.

10.1371/journal.pone.0156018.t005

###### List of functional categories, both biological and molecular, identified with Argot2 for hypothetical cyst proteins.
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  Biological process for hypothetical proteins   Molecular process for hypothetical proteins
  ---------------------------------------------- -----------------------------------------------------------------
  Metabolic process                              Hydrolase activity
  Positive regulation of GTPase activity         ATP binding
  Small GTPase mediated signal transduction      DNA binding
  Phosphorylation                                Guanyl-nucleotide exchange factor activity
  Nucleosome assembly                            Zinc ion binding
  Protein phosphorylation                        Metal ion binding
  Signal transduction                            Transferase activity, transferring phosphorus-containing groups
  Double-strand break repair                     Kinase activity
  rRNA processing                                Nucleic acid binding
                                                 Nucleotide binding
                                                 Protein serine/threonine kinase activity
                                                 RNA binding
                                                 Transferase activity

Discussion {#sec027}
==========

A proteomic comparison among the *E*. *histolytica* trophozoite, cyst, and CLS stages was performed for the first time in this study, employing LC-MS/MS on samples processed in parallel. In addition to contributing to the identification of new stage-specific proteins in trophozoites and cysts, which are completely differentiated parasite stages, the proteome of previously uncharacterized, detergent-resistant structures, was analyzed. These cyst-like structures were obtained *in vitro* by exposing axenic trophozoites to hydrogen peroxide 4 mM for 4 h. Similar structures have been reported by other research groups in trophozoite cultures treated with different stimuli \[[@pone.0156018.ref029]--[@pone.0156018.ref031]\] when attempting to promote *E*. *histolytica* encystment *in vitro*, a critical process for the continuity of the amoeba life cycle and disease transmission. The CLS obtained by our group after oxidative stress showed structural features alike to real cysts, such as multinucleation (2 and 3 nuclei), refringence, size reduction and a chitin-type cover which confers resistance to detergent concentrations that usually lyse trophozoites. In addition, CLS overexpressed the gene encoding for Gln6PI, the first enzyme in the theoretical chitin synthesis pathway in *E*. *histolytica* \[[@pone.0156018.ref032]\]; on the other hand, its knockdown using siRNA drastically reduced the formation of hydrogen peroxide-dependent CLS \[[@pone.0156018.ref033]\]. The absence of animal models for infection with *E*. *histolytica* cysts has hindered the functional comparative studies with CLS, leaving proteomic studies as a promising approach to determine the true nature of CLS and its possible relevance to understand the amoebic encystment process.

A global proteomic analysis by LC-MS/MS showed that CLS are more alike to trophozoites than to cysts. CLS shared 83.4% (459/550) of proteins with trophozoites and only 1.3% (7/550) with cysts. The main differences with trophozoites were seen on the relative abundance of proteins. These results were unexpected, since CLS obtained under exposure to hydrogen peroxide exhibited structural features resembling cysts, as mentioned above \[[@pone.0156018.ref032],[@pone.0156018.ref033]\]. Even though we were unable to identify chitin-associated proteins neither in CLS nor in cysts by LC-MS/MS, we detected the presence of the cyst wall protein Jacob by WB in extracts from both samples but not in trophozoites, demonstrating that at least this protein is present in CLS. The reason behind the difference in size between Jacob proteins identified by WB in cysts and CLS is unknown, but it could be due to variants differentially expressed between the two samples, as it is well known that *E*. *histolytica* has multiple genes encoding for Jacob isoforms \[[@pone.0156018.ref054], [@pone.0156018.ref055]\]. Furthermore, the expression of mRNA encoding for the cyst wall proteins Jessie 1, Jessie 3, and Jacob, but not Jessie 2 nor chitin synthase, were identified by RT-PCR in CLS, suggesting that at least the mRNA encoding for two Jessie and the Jacob proteins were present. Thus, the difficulty in detecting cyst wall proteins in CLS by proteomic analysis might be related to issues in solubilizing chitin covers in the extracts. The previous proteomic study of *E*. *histolytica* cyst detected those proteins after analyzing five individual samples, with a very low peptide-hit score for each protein, supporting the scarcity of chitin wall-associated proteins in the extracts \[[@pone.0156018.ref024]\]. By contrast, in our study we evaluated a pool of cyst samples, and this may have reduced the possibility of detecting cyst wall proteins. Further studies regarding the protein composition of *E*. *histolytica* cyst and CLS walls should be conducted to confirm the presence of those proteins in cysts and to determine whether they are also present in CLS.

Proteome analysis showed that the most abundant CLS proteins include those involved in proton transport, proteolysis, redox homeostasis, and stress response. In addition, proteins involved in glycolysis and metabolism in general were found downregulated with respect to trophozoites, suggesting a protective response against oxidative shock caused by exposure to hydrogen peroxide. Noticeably, a previous report by Tomoyoshi's group showed that oxidative stress inhibits glycolysis while increasing glycerol production, with a concomitant activation of the chitin biosynthesis pathway \[[@pone.0156018.ref056]\]. The results herein reported, along with the previous report on a chitin-like cover in CLS, suggest that these structures could be generated in trophozoites as a rapid survival response to a stressful condition, which allows the parasite to temporarily survive inside a chitin-like resistant cover while the insult passes. Then, we speculate that CLS could revert to trophozoites if favorable conditions are met (our unpublished observations) or under adequate (unknown) stimuli they could follow their differentiation into real cysts, a process that could involve several non-described stages and takes between 24--72 h as it has been described in *E*. *invadens* and *Giardia* sp. \[[@pone.0156018.ref028],[@pone.0156018.ref057]\]. Therefore, encystment could take a long time for a protozoan to respond against environmental stress that can kill it within a few hours or even minutes. Other possibility is that CLS will not proceed to cysts under any circumstance, and both structures are part of different processes. In this regard, structures called \"pseudocysts\" have been reported to form under acute stress conditions, like exposition to organic solvents, in the free-living amoeba *Acanthamoeba*, responsible for keratitis in humans \[[@pone.0156018.ref058], [@pone.0156018.ref059]\]. These structures, which were formed quickly under stress, are partially resistant thanks to a simple coat formed by some of the cyst wall proteins, and are reversible to trophozoite under suitable conditions. Therefore, the authors of that work suggest that encystation and pseudocyst formation are distinct responses to stress. Although the CLS herein studied share some characteristics with *Acanthamoeba* pseudocysts, a similar pseudocyst development has not been reported so far in *E*. *histolytica*; it would be interesting to evaluate this possibility. Further structural, functional, and biochemical characterization studies on CLS are being carried out in our laboratory to confirm this possibility.

On the other hand, the proteomic study herein reported has contributed to the knowledge on the protein profile of the differentiation stages of *E*. *histolytica*, in particular the cyst stage, for which there is only one previous report \[[@pone.0156018.ref024]\]. Thus, the trophozoite proteome described here, equivalent to about 12% of the open reading frames predicted in the available parasite genome \[[@pone.0156018.ref051], [@pone.0156018.ref052]\], reassert it as a highly metabolically active stage, mainly expressing proteins associated to glycolysis/glycogen metabolism and cytoskeleton function, as described elsewhere \[[@pone.0156018.ref010]\]. Based on peptide-hit scores, actin showed the highest relative abundance, followed by proteins associated to proteolysis, phosphorylation, signal transduction, and translation, this latter representing approximately 40% of total proteins. Furthermore, metabolic enzymes such as fructose 1,6-bisphosphate aldolase, NADP-dependent alcohol-dehydrogenase-1, and phosphoglycerate kinase were also identified with high peptide-hit scores. These findings are in agreement with a previous study, where actin and these enzymes were identified as the most prominent spots in solubilized proteins from trophozoite extracts resolved by 2-D SDS \[[@pone.0156018.ref009]\]. In addition, we also detected proteins that have previously been associated with the virulence and pathogenicity of *E*. *histolytica* such as peroxiredoxin and alcohol dehydrogenase 3 \[[@pone.0156018.ref022],[@pone.0156018.ref023]\]. It is noteworthy that 23% of the total number of proteins identified in trophozoites are still uncharacterized, and thus they represent an opportunity for future studies on new therapeutic or diagnostic targets in this parasite stage.

With respect to the cyst, herein we report 411 proteins, a number quite similar to the 417 identified in the only proteomic study of *E*. *histolytica* cysts previously reported \[[@pone.0156018.ref024]\]. The number of cyst proteins identified in both studies was low, probably due to a masking by human and bacterial contaminants, which counted for about 90% of proteins in the samples (data not shown). In total, 299 cyst stage-specific proteins not shared neither with trophozoites nor with CLS were identified in our study. In comparison, 195 proteins were already reported as cyst-specific, of which only 16 were shared by samples in both studies. This adds 283 new proteins to the previously identified set in cysts, contributing to the knowledge of this essential stage of the *E*. *histolytica* life cycle. Moreover, the 16 proteins identified in *E*. *histolytica* cysts isolated from patients from different geographical regions (India and Mexico) should be further explored as targets for cyst-based amoebiasis diagnostic tests; particularly, four of them were theoretically located at the plasma membrane by analysis *in silico* ([Table 4](#pone.0156018.t004){ref-type="table"}). Furthermore, at least seven hypothetical and seven annotated proteins identified in cysts with the highest peptide-hit scores are also probable therapeutic targets for future studies ([Table 3](#pone.0156018.t003){ref-type="table"}). Along with proteins involved in phosphorylation and signal transduction, cyst proteome showed a lower number of proteins in all functional groups ([Fig 3](#pone.0156018.g003){ref-type="fig"}), suggesting a general decrease in the metabolic activity consistent with what is known for latent life-cycle stages. It is noteworthy that 40% of the cyst proteome herein reported are hypothetical proteins, suggesting that our knowledge on the biology of *E*. *histolytica* cyst is still incipient and that the uncharacterized proteins, some of which showed a very high relative abundance, could play an important role in cyst formation and maintenance.

Finally, further structural, functional, and biochemical characterization studies on CLS and cysts should be carried out to determine the real nature of the former and to determine the role of the highly expressed but yet uncharacterized proteins identified in the latter.
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